Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.50 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.50 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.50 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.50 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 2/20 | 0.49 |
| ▸ | ACHE | P22303 | 2/20 | 0.49 |
| ▸ | NT5E | P21589 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.46 |
| ▸ | CDC25B | P30305 | 6/20 | 0.46 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 3/20 | 0.46 |
| ▸ | PTPN6 | P29350 | 2/20 | 0.46 |
| ▸ | TACR2 | P21452 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15973204 | 0.98 | HTR1A (0.53) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL15972562 | 0.87 | HTR1A (0.49) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL12127979 | 0.87 | HTR1A (0.49) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL18681815 | 0.87 | HTR1A (0.49) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL17368112 | 0.87 | HTR1A (0.46) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL12127978 | 0.85 | HTR1A (0.48) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL21657118 | 0.85 | GJB2 (0.56) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL21657199 | 0.85 | HTR1A (0.52) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL21657117 | 0.85 | HTR1A (0.52) | HTR1ASSTR1SSTR2SSTR4SSTR3 | |
| SCHEMBL977853 | 0.85 | SSTR1 (0.59) | HTR1ASSTR1SSTR2SSTR4SSTR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6635622-B2 | Having anti-tumor activity and immunostimulating activity | KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) | 2003-10-21 | — | — | US | disclosed |
| US-20020032158-A1 | Novel glycolipid derivatives | KOTOBUKI PHARMACEUTICAL CO., LTD. (JP) | 2002-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032158-A1 | Novel glycolipid derivatives | SGMS2, SGMS1, HACD3 | HTR1A 2768/4885SSTR1 1731/4885SSTR2 652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.